From Gut to Brain: Evidence for a Causal Contribution of Gut-Microbiota to Major Depressive Disorder in Humans
Fehse, L.; Ribeiro, A. H.; Winter, N. R.; Thanarajah, S. E.; Fisch, L.; Welzel, M.; Bang, C.; Meinert, S.; Flinkenflügel, K.; Borgers, T.; Goltermann, J.; Leehr, E. J.; Bloemendaal, M.; Natasha, E. E.; Mulder, D.; Vasquez, A. A.; Stein, F.; Thomas-Odenthal, F.; Usemann, P.; Teutenberg, L.; Nenadic, I.; Straube, B.; Alexander, N.; Jamalabadai, H.; Jansen, A.; Nitsch, R.; Lügering, A.; Reif, A.; Kittel-Schneider, S.; Cryan, J.; Franke, A.; Valderrama, B.; Clarke, G.; Lavelle, A.; Dannlowski, U.; Kircher, T.; Heider, D.; Hahn, T.
Show abstract
Major Depressive Disorder (MDD) is a highly prevalent, severe mental health condition that constitutes one of the leading causes of disability worldwide. While recent animal studies suggest a causal role of the gut microbiome in the pathophysiology of MDD models, evidence in humans is still unclear due to small sample sizes, inconsistent clinical assessment of MDD diagnosis, and methodological limitations regarding causal inference in cross-sectional data. Here, we explicitly address these shortcomings to investigate the potential causal link between the gut microbiome and MDD: First, we replicate previous findings using one of the largest multicenter MDD cohorts for which microbiome data and in-depth diagnostic assessment are available (N=1,269 MDD patients and controls). We find a significant difference between healthy controls and MDD patients for the relative abundance of the four taxa Eggerthella, Hungatella, Coprobacillus, and Lachnospiraceae FCS020. Second, we employ state-of-the-art, fully data-driven causal inference tools within Judea Pearls framework, allowing us to derive model constraints from the data rather than relying on potentially strong, unrealistic assumptions. Using this approach, we found data-driven evidence for Eggerthella and Hungatella as causal contributors to MDD. Furthermore, we show that Eggerthella and Hungatella abundances are associated with MDD beyond the influence of body mass index, identifying two distinct pathways linking MDD to the gut microbiome. Finally, the difference in relative abundance of these taxa between healthy and MDD patients was independent of antidepressant medication. Our study provides the first evidence for a potential causal role of gut-microbiota in the pathophysiology of depression in humans.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Comparative Analysis of the Duodenojejunal Microbiome with the oral and fecal microbiome unveils its role in Human Severe Obesity 94%
- Gut microbiome shifts in adolescents after sleeve gastrectomy with increased oral-associated taxa and pro-inflammatory potential 94%
- Longitudinal analysis of the gut microbiome in adolescent patients with anorexia nervosa: microbiome-related factors associated with clinical outcome 94%
Similar papers in this journal
Similar papers in this journal
Similar papers in this journal
- Medication Use is Associated with Distinct Microbial Features in Anxiety and Depression 96%
- Immunological Drivers and Potential Novel Drug Targets for Major Psychiatric, Neurodevelopmental, and Neurodegenerative Conditions 94%
- Epigenetic and Genetic Profiling of Comorbidity Patterns among Substance Dependence Diagnoses 93%
Similar papers in this journal
- A methylome-wide association study of major depression with out-of-sample case-control classification and trans-ancestry comparison 93%
- Stomach-brain coupling indexes a dimensional signature of mental health. 92%
- Characterizing the phenotypic and genetic structure of psychopathology in UK Biobank 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.